Stroke is the leading cause of long term disability in developed countries and one of the top
causes of mortality worldwide. The past decade has seen substantial advances in the …

Stroke is a leading cause of permanent disability. Therefore, primary prevention of first
stroke and secondary prevention of recurrent stroke are a high priority. Primary prevention of …

These guidelines will be updated every four years. Vascular centres are encouraged to audit
implementations made as a result of the guidelines. Audit cycles should be repeated and …

Introduction Although there is evidence to suggest a high rate of cerebrovascular
complications in patients with SARS-CoV-2 infection, anecdotal reports indicate a falling rate …

Importance Dual antiplatelet therapy with clopidogrel and aspirin is effective for secondary
prevention after minor ischemic stroke or transient ischemic attack (TIA). Uncertainties …

Acute ischaemic stroke is a major public health priority and will become increasingly
relevant to neurologists of the future. The cornerstone of effective stroke care continues to be …

Background People with factor XI deficiency have lower rates of ischaemic stroke than the
general population and infrequent spontaneous bleeding, suggesting that factor XI has a …

Objective: A literature review of antiplatelet agents for primary and secondary stroke
prevention, including mechanism of action, cost, and reasons for lack of benefit. Data …

BACKGROUND: It is unclear whether patients with different stroke/transient ischemic attack
etiologies benefit differently from gene-directed dual antiplatelet therapy. This study …

Contrary to many reports that antiplatelet agents inhibit cancer growth and metastasis, new
solid tumors have been reported in patients receiving long-term antiplatelet therapy. We …